Close Menu

Applied Markets

News on genetics and genomics applications in the Ag-Bio, Veterinary, Forensics, Food Safety, and Environmental Testing markets.

The Tokyo-based firm is looking to expand into the US market following a recent ¥700 million ($6.6 million) Series B financing round.

Driving the shift is a belief that standard STR testing is not always a reliable tool for determining complex family relationships.

The companies, which have been working since early 2019, will work together on Evonetix's first product, a desktop DNA synthesizer.

Horizons Ventures led the round, joined by Airbus Ventures, bringing the MIT spinout's fundraising total to date to more than $21 million.

he single-cell microbiome sequencing firm has raised a total of ¥1.5 billion in equity financing since its founding in 2018.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.